Skip to Content
Morningstar
Get 14 Days Free

Henry Schein Inc HSIC

Morningstar Rating
Rating as of

Morningstar’s Analysis

There is no Morningtar’s Analysis data available.

Company Profile

Business Description

Henry Schein is the largest wholesaler of dental and medical products to office-based practitioners. The company has been established for approximately 90 years and operates across nearly 30 distribution centers to offer hundreds of thousands of products to customers globally. Henry Schein also offers practice management products that include software products, technical, financial, and educational services. The company recently spun off its animal health business.

Contact
135 Duryea Road
Melville, NY, 11747
T +1 631 843-5500
Sector Healthcare
Industry Medical Distribution
Most Recent Earnings Mar 31, 2021
Fiscal Year End Dec 25, 2021
Stock Type Slow Growth
Employees 20,000

Related

Premium Article
16 Overpriced Stocks With Eroding Moats
These narrow-moat stocks all have negative moat trends and are trading at 1- or 2-star levels.
Susan Dziubinski
Stock Strategist
McKesson's Our Favorite Undervalued Healthcare Distributor
We like its improving operational dynamics and less uncertain near-term environment.
Vishnu Lekraj
US Videos
2 Wide Moats in Health Care
Distributors Henry Schein and Patterson should be able to maintain their competitive advantages over the long run and deserve a spot on investors' watchlists.
Michael Waterhouse
Stock Strategist Industry Reports
Unique Characteristics in Dental and Veterinary Distributor Markets Support Wide Economic Moats
We've upgraded our moat ratings for Henry Schein and Patterson Companies to wide on distribution network cost advantages and high switching costs among their fragmented customers and suppliers.
Michael Waterhouse
Stock Strategist
A Look at the Veterinary Supply Segment
Veterinary segments may contain hidden value for both Patterson and Schein.
Bill Buhr
US Videos
Two Buckets of Growth Picks
Early Manager of the Year contender Joe Milano of T. Rowe Price New America Growth highlights the portfolio's mix of durable and mature growth companies and his positioning for 2010.
Harry Milling
Stock Strategist Industry Reports
Dental Industry Provides Opportunities
The dental industry has attractive long-term characteristics.
Bill Buhr
Quarter-End Insights
Our Outlook for the Health-Care Sector
We think big pharma's pipelines are looking healthier--it's time to buy.
Debbie Wang

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.